Prestige Consumer Healthcare (PBH) Return on Capital Employed (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Return on Capital Employed of 9.68% in Q4 2025, down 3.63% quarter-over-quarter from 10.05% in Q3 2025, and down 58.0% on a YoY basis from 23.05% in Q4 2024.
Prestige Consumer Healthcare (PBH) Return on Capital Employed (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Return on Capital Employed history runs 15 years deep, the most recent figure standing at 9.68% for Q4 2025.
- In Q4 2025, Return on Capital Employed fell 58.0% year-over-year to 9.68%; the TTM figure through Dec 2025 stood at 9.68% (down 58.0% YoY), while the FY2025 annual figure was 10.35%, down 29.0% from the prior year.
- Return on Capital Employed was 9.68% for Q4 2025 at Prestige Consumer Healthcare, down from 10.05% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 10.66% in Q1 2024 to a low of 0.76% in Q2 2023.
- Historically, Return on Capital Employed has averaged 7.63% across 5 years, with a median of 9.38% in 2022.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed tumbled 1010 bps in 2023, then jumped 1132 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 9.16% in 2021, then climbed by 3 bps to 9.45% in 2022, then sank by 107 bps to 0.65% in 2023, then soared by 1689 bps to 10.26% in 2024, then decreased by 6 bps to 9.68% in 2025.
- The last three Return on Capital Employed figures came in at 9.68% (Q4 2025), 10.05% (Q3 2025), and 10.17% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 9.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.68% |
| Sep 30, 2025 | 10.05% |
| Jun 30, 2025 | 10.17% |
| Mar 31, 2025 | 10.33% |
| Dec 31, 2024 | 10.26% |
| Sep 30, 2024 | 10.15% |
| Jun 30, 2024 | 10.29% |
| Mar 31, 2024 | 10.66% |
| Dec 31, 2023 | -0.65% |
| Sep 30, 2023 | -0.63% |
| Jun 30, 2023 | -0.76% |
| Mar 31, 2023 | -0.66% |
| Dec 31, 2022 | 9.45% |
| Sep 30, 2022 | 9.39% |
| Jun 30, 2022 | 9.25% |
| Mar 31, 2022 | 9.37% |
| Dec 31, 2021 | 9.16% |
| Sep 30, 2021 | 9.06% |
| Jun 30, 2021 | 9.16% |
| Mar 31, 2021 | 8.94% |